Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Cancer Research|June 20, 2015
Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In VivoPeibin Yue, Francisco Lopez-Tapia, David Paladino, et al.
Chemical Communications (Cambridge, England)|January 29, 2010
Coordination complex SH2 domain proteomimetics: an alternative approach to disrupting oncogenic protein-protein interactionsJoel A Drewry, Steven Fletcher, Peibin Yue, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2007
Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of STAT SH2 domainsPatrick T Gunning, William P Katt, Matthew Glenn, et al.
Journal of Medicinal Chemistry|December 14, 2011
Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activityBrent D G Page, Haytham Khoury, Rob C Laister, et al.
Nature Cell Biology|February 22, 2011
Stat3 controls lysosomal-mediated cell death in vivoPeter A Kreuzaler, Anna D Staniszewska, Wenjing Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2012
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenograftsXiaolei Zhang, Peibin Yue, Brent D G Page, et al.
Cancer Research|March 11, 2010
Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of CtenIsaia Barbieri, Sara Pensa, Tania Pannellini, et al.
Pageof 9